Pehek E A, Yamamoto B K
Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio.
J Neurochem. 1994 Dec;63(6):2118-24. doi: 10.1046/j.1471-4159.1994.63062118.x.
Previous research has shown that systemically administered antipsychotic drugs enhance dopamine release from the nigrostriatal and mesocortical dopamine pathways. However, the degree of enhancement differs as a function of the drug used (atypical versus typical antipsychotic) and the dopamine pathway examined. The present studies examined whether these differences result from differential actions of these drugs on dopamine terminal regions. Clozapine or haloperidol was infused locally into the caudate-putamen or prefrontal cortex through reverse microdialysis. Although both drugs increased extracellular dopamine levels, clozapine produced greater effects than haloperidol in the prefrontal cortex, whereas haloperidol produced greater effects in the caudate-putamen. These results suggest that neurochemical differences within dopamine terminal regions may explain the differential actions of antipsychotic drugs on striatal and cortical dopamine release.
先前的研究表明,全身给药的抗精神病药物会增强黑质纹状体和中皮质多巴胺通路的多巴胺释放。然而,增强程度因所使用的药物(非典型与典型抗精神病药物)以及所检测的多巴胺通路而异。本研究考察了这些差异是否源于这些药物对多巴胺终末区域的不同作用。通过反向微透析将氯氮平或氟哌啶醇局部注入尾状核 - 壳核或前额叶皮质。尽管两种药物都增加了细胞外多巴胺水平,但氯氮平在前额叶皮质产生的作用比氟哌啶醇更大,而氟哌啶醇在尾状核 - 壳核产生的作用更大。这些结果表明,多巴胺终末区域内的神经化学差异可能解释了抗精神病药物对纹状体和皮质多巴胺释放的不同作用。